You are here: Industry Insights > Cobra

News List

Cobra Biologics, CombiGene Ready to Start GMP Production of Epilepsy Drug Candidate contractpharma
June 28, 2021
Complete production and quality assurance of the plasmids to be used in the GMP production of CG01.
Albumedix Extends Research Collaboration with Cobra Biologics contractpharma
May 06, 2021
Albumedix has extended its research collaboration with Cobra Biologics, the gene therapy division of Cognate BioServices, a Charles River Laboratories International company.
Cognate BioServices Announces Major Expansion contractpharma
January 19, 2021
Cognate BioServices Inc. has announced plans to expand cell and gene therapy manufacturing capacity, laboratory space, warehousing capabilities, and increase office support at its facilities in the United States and Europe.
Cobra Biologics and Symbiosis Complete Viral Vector Supply Chain contractpharma
June 26, 2019
Develops capabilities intended to accelerate the clinical and commercial production of viral vectors.
Cobra, Pall, Cell and Gene Therapy Catapult Win £1.5M Innovate UK Grant contractpharma
November 27, 2018
Cobra Biologics has won a £1.5m shared grant from Innovate UK, the United Kingdom’s innovation agency. Co-winners, Pall Corporation and the Cell and Gene Therapy Catapult will work with Cobra Biologics to investigate continuous manufacturing of adeno-asso
Cobra awarded £2.6m from Innovate UK for expansion pharmatimes
January 25, 2018
Keele, UK-based Cobra Biologics is being handed £2.6 million by Innovate UK to help the firm expand and develop its infrastructure.
Cobra Biologics Invests $19m in Gene Therapy Mfg. Expansion contractpharma
April 19, 2017
Capacity increase in response to customer demand for DNA and viral vector production
Cobra Biologics Helps Alligator Bio Complete Phase I Trial contractpharma
April 14, 2017
maxXpress platform used to enable rapid and high-yielding expression of protein ADC-1013